LY3437943 may cause greater weight loss than Tirzepatide , a dual GIPR and GLP-1R agonist that has shown improved weight loss compared to selective GLP-1R agonists in patients with type 2 diabetes
Research has shown it acts like an exercise-mimetic, improving metabolic health
We thank the Stanford Veterinary Service Center staff for their assistance with animal care and procedures
It is not supplied for human consumption, medical use, veterinary use, clinical use, diagnostic use, treatment, cure, or prevention of disease
J Pediatr 1983, 103: 175-176
Nguyen VT, Tung NT, Cuong TD et al (2015) Cytotoxic and anti-angiogenic effects of lanostane triterpenoids from Ganoderma lucidum